| A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. (NCT04671693) | Centre Leon Berard | 2020-12-24 |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 (NCT02890758) | Brenda Cooper, MD | 2018-05-22 |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas (NCT03442465) | Memorial Sloan Kettering Cancer Center | 2018-02-14 |
| Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma (NCT02736565) | Gradalis, Inc. | 2016-10-01 |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors (NCT02689336) | Washington University School of Medicine | 2016-08-06 |
| A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma (NCT02511132) | Gradalis, Inc. | 2016-02-10 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors (NCT01962103) | Celgene | 2013-12-04 |
| Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy (NCT01674101) | St. Jude Children's Research Hospital | 2012-09-01 |
| Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients (NCT01734863) | Children's Cancer Hospital Egypt 57357 | 2012-09-01 |
| Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma (NCT01583543) | Massachusetts General Hospital | 2012-05-01 |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI (NCT01336803) | Heike E Daldrup-Link | 2011-08-01 |
| Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma (NCT01313884) | Stanford University | 2011-05-01 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides (NCT01598454) | Laboratorio Elea Phoenix S.A. | 2011-02-01 |
| Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy (NCT01222767) | PharmaMar | 2010-12-01 |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients (NCT01169584) | Jennerex Biotherapeutics | 2010-08-01 |
| Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults (NCT01696669) | Grupo Espanol de Investigacion en Sarcomas | 2010-03-30 |
| Study in Localized and Disseminated Ewing Sarcoma (NCT00987636) | University Hospital Muenster | 2009-10-01 |
| Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma (NCT02063022) | Italian Sarcoma Group | 2009-01-22 |
| Informed Consent in Pediatric Cancer Trials (NCT00923650) | National Cancer Institute (NCI) | 2008-12-09 |
| QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors (NCT00563680) | NantCell, Inc. | 2007-10-01 |
| HGS-ETR2 to Treat Children With Solid Tumors (NCT00428272) | National Cancer Institute (NCI) | 2006-12-04 |
| Aerosol L9-NC and Temozolomide in Ewing's Sarcoma (NCT00492141) | M.D. Anderson Cancer Center | 2006-06-01 |
| Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma (NCT00541411) | King Faisal Specialist Hospital & Research Center | 2003-06-01 |
| Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy (NCT00004853) | National Cancer Institute (NCI) | 2000-03-03 |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors (NCT00179816) | Ann & Robert H Lurie Children's Hospital of Chicago | 1999-04-01 |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases (NCT00001686) | National Cancer Institute (NCI) | 1998-03-19 |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients (NCT00038142) | M.D. Anderson Cancer Center | 1997-11-01 |
| A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas (NCT00001564) | National Cancer Institute (NCI) | 1996-12-23 |
| A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas (NCT00001566) | National Cancer Institute (NCI) | 1996-12-01 |
| New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma (NCT00001335) | National Cancer Institute (NCI) | 1993-04-01 |